ABC's Oncology Business Still Strong Despite Medicare Reimbursement Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
AmerisourceBergen is "cautiously" optimistic about the impact of oncology reimbursement on its Specialty Group business through the rest of the calendar year. The wholesaler previously said it expected the change in Medicare Part B drug reimbursement to have a negative effect on revenues.